12471 results for
Refine Your Search
Steve
Happy Pride! As a member of LLS’s new LGBTQIA+ employee resource group, Prism Alliance, and as staff in the Office of Public Policy (OPP), I’m excited…
MorphoSys to Acquire Constellation Pharmaceuticals
PLANEGG/MUNICH, Germany & CAMBRIDGE, Mass. Jun. , - MorphoSys AG (FSE: MOR; NASDAQ: MOR) (“MorphoSys”), and Constellation Pharmaceuticals, Inc., (NASD…
TAP Partner News During EHA: June 2021
Current and former TAP partners presented new data during the virtual European Hematology Association (EHA) meeting that took place from June -17th.
TAP Partner News During ASCO: June 2021
Current and former TAP partners presented new data during the virtual American Society of Clinical Oncology (ASCO) meeting that took place from June …
Carisma Therapeutics Presents Clinical Trial Design at ASCO 2021 Meeting
CARISMA Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, will make a p…
June 2021 Patient Education Programs
Myeloma: Updates on Diagnosis, Treatment, and Support A Virtual Education Program (New England Region June , :00pm – :30pm (CT) https://na.eventsclou…
Corporate Partnerships with LLS
The Leukemia & Lymphoma Society is committed to curing cancer, and we need your help. From event sponsors to employee engagement and retail activatio…
Cindy
Our church choir had put on a big Easter program in , lots of practices and multiple performances. After the fact, several, including me, came down wi…
New Series-Research Highlight: Acute Lymphoblastic Leukemia-New Targets, Pathways and Therapies
LLS Community is launching a new series focused on highlighting research in blood cancer. The first in this series focuses on Acute Lymphoblastic Leuk…
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021
BOSTON, June , - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting f…
Ryvu Therapeutics Presents Positive Phase I Data for RVU120 at the Virtual EHA Congress
Krakow, Poland – June, – Ryvu Therapeutics [WSE:RVU] today announced the online publication of two posters and an oral presentation demonstrating cl…
Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
CAMBRIDGE, Mass., June , (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a biopharmaceutical company using its expertise in …
Hodgkin Lymphoma 3D Model
This model contains the following chapters. Click the "Interact in 3D" button to begin.Healthy Bone MarrowNormal Blood Cell ProductionProliferation of…
3D Models
Non-Hodgkin Lymphoma 3D Model
This model contains the following chapters. Click the "Interact in 3D" button to begin.Healthy Bone MarrowNormal Blood Cell ProductionProliferation of…
3D Models
Myeloproliferative Neoplasms 3D Model
This model contains the following chapters. Click the "Interact in 3D button" to begin.Healthy Bone MarrowNormal Blood Cell ProductionEssential Thromb…
3D Models
Myelodysplastic Syndromes 3D Model
.{ display:none;} @media only screen and (: 767px) { .{ display: none;} .{ display: block;} }This model contains the following chapters. Click the "In…
3D Models
Chronic Myeloid Leukemia 3D Model
This model contains the following chapters. Click the "Interact in 3D" button to begin.Healthy Bone MarrowNormal Blood Cell ProductionProliferation of…
3D Models
Chronic Lymphocytic Leukemia 3D Model
This model contains the following chapters. Click the "Interact in 3D" button to begin.Healthy Bone MarrowNormal Blood Cell ProductionProliferation of…
3D Models
Acute Myeloid Leukemia 3D Model
This model contains the following chapters. Click the "Interact in 3D" button to begin.Healthy Bone MarrowNormal Blood Cell ProductionProliferation of…
3D Models